Aurora Cannabis announced it has entered into a strategic agreement with MedReleaf Australia. The companies have signed a five-year supply agreement, which provides for MedReleaf to act as the exclusive supplier in Australia of Aurora’s MedReleaf, CanniMed and Aurora brands. Products covered by the agreement will be EUGMP certified and include dried flower, oils, and soft gels, as well as future products employing new delivery mechanisms. The agreement does not require or include any capital investment by Aurora. This agreement will advance the Australian medical cannabis offering of both companies and extend availability of high-quality, medical cannabis to patients.
Source: Company filings
